Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
Filter results of approved projects table below
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Modification of Ovarian, Endometrial, Colorectal, and Breast Cancer risks associated with Oral Contraceptive use | Kara Michels | Division of Cancer Epidemiology and Genetics, National Cancer Institute | PLCO | Oct 28, 2016 | PLCO-238 |
| Modification of the Associations Between Aspirin Use and Colorectal, Ovarian, Endometrial, Breast, and Prostate Cancer Risk | Lauren Hurwitz | National Cancer Institute | PLCO | Oct 4, 2018 | PLCO-403 |
| Modified Lung-RADS classification incorporating nodule risk calculator. | Alain Tremblay | THE GOVERNORS OF THE UNIVERSITY OF CALGARY | NLST | Nov 5, 2021 | NLST-849 |
| Modifying Effects of Variant Oxidative Stress Related Genes in Relation to Prostate Cancer Outcomes | LaCreis Kidd | University of Louisville | PLCO | Jan 21, 2010 | 2009-0244 |
| Modular approach to comprehensive oncological decision support | Daniel Schneider | Innovation Center Computer Assisted Surgery, Leipzig University | PLCO | Jul 22, 2021 | PLCO-813 |
| Molecular characterization of bladder tumors and studies of etiologic heterogeneity in the PLCO Trial | Stella Koutros | National Cancer Institute | PLCO | Mar 14, 2017 | 2016-0045 |
| Molecular characterization of breast tumors in relation to risk factors and survival | Montserrat Garcia-Closas | National Cancer Institute | PLCO | Sep 22, 2016 | 2016-0017 |
| Molecular characterization of ovarian cancers in PLCO: Evaluating subgroups and prognostic signatures | Nicolas Wentzensen | NCI | PLCO | Jun 12, 2018 | 2016-0020 |
| Molecular pathological epidemiology of colorectal cancer | Ulrike Peters | Fred Hutchinson Cancer Center | PLCO | Jul 22, 2014 | PLCO-98 |
| Molecular Risk Stratification for Colonoscopic Surveillance | ANDREW T. Chan | MASSACHUSETTS GENERAL HOSPITAL | PLCO | 2015-0101 | |
| Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO | Paramita Saha-Chaudhuri | McGill University | PLCO | Oct 12, 2018 | PLCO-408 |
| Mortality and Morbidity Following Prostate Biopsy | Paul Pinsky | NCI, DCP, EDRG | PLCO | Jan 17, 2013 | PLCO-12 |
| Mortality benefit from lung cancer screening | Deepthi Mani | University of Washington | NLST | Jul 19, 2016 | NLST-230 |
| Mortality prediction using a combination of quantitive CT image measures | Anton Schreuder | Radboudumc | NLST | Sep 5, 2018 | NLST-437 |
| Mortality Reduction by year | Rowena Yip | Icahn School of Medicine at Mount Sinai | NLST | Apr 17, 2013 | NLST-16 |
| Mortality Reduction by year | Rowena Yip | Icahn School of Medicine at Mount Sinai | PLCO | Apr 15, 2013 | PLCO-24 |
| Mortality Reduction by year | Rowena Yip | Mount Sinai School of Medicine | PLCO | May 29, 2024 | PLCOI-1574 |
| Mortality reductions produced by a sustained low-dose helical CT screening program for lung cancer | James Hanley | McGill University | NLST | May 24, 2013 | NLST-19 |
| MRI screening for lung cancer: Markov modeling using the NLST CT outcomes data | Mark Schiebler | UW-Madison School of Medicine and Public Health | NLST | Dec 15, 2016 | NLST-265 |
| MRI screening for lung cancer: Markov modeling using the NLST CT outcomes data | Bradley Allen | Northwestern University | PLCO | Aug 29, 2017 | PLCO-300 |